Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Appili Therapeutics Inc. has issued a correction to a previous press release regarding the proposed financial terms of their arrangement with Aditxt, Inc. The corrected terms now state that shareholders will receive $0.0467 in cash per Class A common share instead of the previously stated $0.467. This amendment alters the cash consideration but leaves the rest of the initial release unchanged.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.